Doximity filings document financial results, material events, governance actions, and capital-structure details for the operator of a digital platform for U.S. medical professionals. Recent Form 8-K disclosures cover quarterly results and related exhibits, finance and legal leadership changes, Regulation FD updates, and annual-meeting voting outcomes.
The company's regulatory record also includes shareholder voting matters tied to its Class A and Class B common stock structure, director elections, auditor ratification, material agreements, and other security-holder matters. These filings describe how Doximity reports operating performance, governance changes, voting mechanics, and formal public-company events.
Doximity, Inc. Chief Accounting Officer Siddharth Sitaram exercised stock options covering 5,000 shares at an exercise price of $4.12 per share and 3,000 shares at an exercise price of $8.26 per share on October 14, 2026, and converted 8,000 Class B shares into 8,000 Class A shares. He also sold 2,613 Class A shares at $30.68 per share in a sell-to-cover transaction for tax withholding; the sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted February 27, 2026.
Doximity, Inc. officer Siddharth Sitaram reported a proposed sale of 2,613 common shares, with an approximate sale date of October 14, 2026 and an aggregate market value of $80,166.84. The shares are listed as acquired from the issuer through a stock option exercise, with cash payment. Sitaram also reported sales of 2,077 shares on September 15, 2026, 1,770 on August 13, 2026, and 1,732 on July 15, 2026.
Doximity, Inc. (DOCS) director Kira Scherer Wampler exercised 2,000 stock options at $1.54 per share on October 1, 2026, receiving 2,000 Class B shares. She converted those shares one-for-one into Class A and sold 2,000 Class A shares at $28.91 per share. The sale occurred automatically under a Rule 10b5-1 trading plan adopted May 26, 2026. The reported stock-option balance after the exercise was 441,700 shares.
Doximity, Inc. (DOCS) director Watkin Phoebe L. Yang sold 1,290 shares of Class A common stock at $26.71 per share on September 30, 2026. Direct holdings following the sale were 24,744 shares. The sale occurred automatically under a Rule 10b5-1 trading plan adopted on May 22, 2026.
Doximity, Inc. director Kira Wampler reported an intended sale of 2,000 common shares, listed for October 1, 2026, with an aggregate market value of $57,820. The shares are listed as acquired from the issuer through a stock option exercise for cash on October 1, 2026. Her prior sales during the preceding three months were 2,000 shares on August 25, 2026, with gross proceeds of $49,900, and 2,000 shares on September 1, 2026, with gross proceeds of $52,660.
Doximity, Inc. director Phoebe L. Yang Watkin reported a proposed sale of 1,290 shares of common stock, with an aggregate market value of $34,455.90. Morgan Stanley Smith Barney LLC is listed as the broker, and September 30, 2026, is the approximate sale date.
Doximity, Inc. President Steven L. Zatz received two direct restricted stock unit (RSU) grants on September 24, 2026: 48,927 RSUs and 103,500 RSUs. The first grant vests 50% on November 15, 2026, and 50% on February 15, 2027. The second vests in equal quarterly installments over 12 months beginning May 15, 2027. Both schedules are subject to his continuous service through each applicable vesting date; each RSU represents a contingent right to receive one share of Class A common stock.
Doximity, Inc. (DOCS) reports that Chief Accounting Officer Siddharth Sitaram exercised stock options for 5,000 shares of Class B Common Stock on September 15, 2026, which converted into Class A Common Stock, and then sold 2,077 Class A shares in a sell-to-cover tax transaction.
The option had an exercise price of $4.12 per share, expires on December 21, 2030, and this exercise left 54,000 option shares reported as held directly. The sales occurred automatically under a Rule 10b5-1 trading plan adopted on February 27, 2026.
Doximity, Inc. (DOCS) has an officer, Siddharth Sitaram, providing notice under Rule 144 of a proposed sale of 2,077 shares of common stock through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $54,043.54. The notice states that 127,349,369 shares of Doximity common stock are outstanding and lists the NYSE as the exchange.
The shares to be sold are shown as being acquired on September 15, 2026 via a stock option exercise, with cash as the form of payment. The notice also reports that Siddharth Sitaram sold 1,770 shares for $44,143.80 on August 13, 2026 and 1,732 shares for $38,138.64 on July 15, 2026.
Doximity, Inc. (DOCS) director Kira Scherer Wampler reported an option exercise and related share sale. On September 1, 2026, she exercised options for 2,000 shares of Class B Common Stock at an exercise price of $1.54 per share, leaving 443,700 options outstanding from that grant. The 2,000 Class B shares converted into 2,000 Class A shares, which were then sold at $26.33 per share pursuant to a Rule 10b5-1 trading plan.